# An Ascending, Single Oral Dose Pharmacokinetic Study of 3'-Deoxy-3'-Fluorothymidine (FLT) in Asymptomatic Human Immunodeficiency Virus (HIV)-Infected Subjects

> **NCT00002271** · NA · COMPLETED · sponsor: **Lederle Laboratories**

## Conditions studied

- HIV Infections

## Interventions

- **DRUG:** Alovudine

## Key facts

- **NCT ID:** NCT00002271
- **Lead sponsor:** Lederle Laboratories
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2005-06-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00002271

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00002271, "An Ascending, Single Oral Dose Pharmacokinetic Study of 3'-Deoxy-3'-Fluorothymidine (FLT) in Asymptomatic Human Immunodeficiency Virus (HIV)-Infected Subjects". Retrieved via AI Analytics 2026-08-11 from https://api.ai-analytics.org/clinical/NCT00002271. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*